Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00705380 · ClinicalTrials.gov registry record · Phase 2

Effectiveness of Cognitive Behavioral Therapy With Panic Control Treatment for Adolescents With Panic Disorder

A Phase 2 study of Panic Disorder, sponsored by Boston University.

Completed
Registry status
Phase 2
Development phase
25
Enrollment target
1
Study location

NCT00705380 is a Phase 2 study of Panic Disorder that has completed, run by Boston University. The registered enrollment target is 25 participants, below the 222-participant average among 25 other Panic Disorder trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00705380, a Phase 2 study of Panic Disorder, has completed, sponsored by Boston University.

COMPLETED
Registry status
Phase 2
Development phase
25 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate the effectiveness of cognitive behavioral therapy with a panic control treatment component in treating adolescents with panic disorder.

Conditions Studied

Interventions

  • BEHAVIORAL Waitlist control
  • BEHAVIORAL Cognitive behavioral therapy (CBT) with panic control treatment (PCT) for adolescents

Study Locations (1)

Massachusetts

  • Boston University - Boston

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 1998-07
Est. Completion 2004-10
Phase Phase 2

Sponsor

Boston University

185 total trials

What the Registry Record Tells You About NCT00705380

The ClinicalTrials.gov registry entry for NCT00705380 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 222-participant average among 25 other Panic Disorder trials with a reported enrollment target (89% lower). The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Panic Disorder appearing as the primary indexed condition, and to 2 interventions - of which Waitlist control is the first listed.

NCT00705380 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00705380 about?

NCT00705380 is a clinical study titled "Effectiveness of Cognitive Behavioral Therapy With Panic Control Treatment for Adolescents With Panic Disorder". This study will evaluate the effectiveness of cognitive behavioral therapy with a panic control treatment component in treating adolescents with panic disorder.

What is the current status of trial NCT00705380?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 25 participants. The study started on 1998-07. Estimated completion is 2004-10.

What conditions does trial NCT00705380 study?

This clinical trial studies the following conditions: Panic Disorder.

What interventions are being tested in trial NCT00705380?

The interventions under investigation include: Waitlist control (BEHAVIORAL), Cognitive behavioral therapy (CBT) with panic control treatment (PCT) for adolescents (BEHAVIORAL).

Who is sponsoring clinical trial NCT00705380?

This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00705380 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Panic Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.